On Monday President Donald Trump signed an executive order aimed at accelerating science using artificial intelligence, an effort dubbed the “Genesis Mission.” National security, scientific discovery ...

Artificial intelligence is accelerating material discovery and design by automating analysis, guiding experiments, and enabling predictive modeling across spectroscopy, microscopy, and synthesis.

GREEN BAY (WLUK) -- Microsoft announced a new partnership with TitletownTech and the University of Wisconsin-Madison. “TechSpark is a Microsoft initiative that we began almost 10 years ago. Really, we ...

Artificial intelligence promises to accelerate scientific discovery and open new frontiers of inquiry. But new research from ...

The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...

AI supercharges discovery; Nye and Afeyan warn U.S. anti-science cuts threaten health, competitiveness, future today.

Data science has revolutionized the hunt for high-performing catalysts, enabling scientists to quickly identify and test suitable materials. The integration of data science into electrocatalysis has ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

核酸适配体（Aptamer）是一类短的单链 DNA 或 RNA 寡核苷酸，通过形成三维空间结构，靶向结合特定蛋白或者细胞发挥作用，其具有广泛优点，包括高度特异性、易于合成、可定制、热稳定性好、分子小、组织穿透能力强等。成为选择性靶向特定蛋白质或细胞以治疗多种疾病类型的新选择。